Recro Pharma, Inc. - Current Ratio

The Current Ratio as of August 2026 (TTM) for Recro Pharma, Inc. (REPH) is 1.07

According to Recro Pharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.07. This represents a change of -48.06% compared to the average of 2.06 of the last 4 quarters.

Recro Pharma, Inc. (REPH) Historical Current Ratio (quarterly & annually)

How has REPH Current Ratio performed in the past?

The mean historical Current Ratio of Recro Pharma, Inc. over the last ten years is 5.05. The current 1.07 Current Ratio has changed 2.02% with respect to the historical average. Over the past ten years (40 quarters), REPH's Current Ratio was at its highest in in the March 2014 quarter at 36.65. The Current Ratio was at its lowest in in the December 2023 quarter at 1.07.

Recro Pharma, Inc. (REPH) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Recro Pharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Recro Pharma, Inc. (REPH) Average Current Ratio

How has REPH Current Ratio performed in the past?

The current Current Ratio of Recro Pharma, Inc. (REPH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Recro Pharma, Inc. (REPH) Current Ratio vs. Peers

How is REPH’s Current Ratio compared to its peers?

Recro Pharma, Inc.’s Current Ratio is greater than Theratechnologies Inc. (0.84), less than Theseus Pharmaceuticals, Inc. (17.79), less than BioSig Technologies, Inc. (20.21), less than LENZ Therapeutics, Inc. (13.55), greater than Shineco, Inc. (0.76), greater than LakeShore Biopharma Co., Ltd (1.02), less than Vaccitech plc (5.54), less than Zevra Therapeutics, Inc. (5.17), less than F-star Therapeutics, Inc. (6.98), greater than Procaps Group S.A. (0.69),

Build a custom stock screener for Recro Pharma, Inc. (REPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Recro Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Recro Pharma, Inc. (REPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Recro Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.